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Abstract
The oviduct is an exquisitely designed organ that functions in picking-up ovulated oocytes,
transporting gametes in opposite directions to the site of fertilization, providing a suitable
environment for fertilization and early development, and transporting preimplantation embryos to
the uterus. A variety of biological processes can be studied in oviducts making them an excellent
model for toxicological studies. This review considers the role of the oviduct in oocyte pick-up and
embryo transport and the evidence that chemicals in both mainstream and sidestream cigarette
smoke impair these oviductal functions. Epidemiological data have repeatedly shown that women
who smoke are at increased risk for a variety of reproductive problems, including ectopic
pregnancy, delay to conception, and infertility. In vivo and in vitro studies indicate the oviduct is
targeted by smoke components in a manner that could explain some of the epidemiological data.
Comparisons between the toxicity of smoke from different types of cigarettes, including harm
reduction cigarettes, are discussed, and the chemicals in smoke that impair oviductal functioning
are reviewed.
A. Background
Exposure to cigarette smoke may be either active or pas-
sive, and the type of smoke inhaled in each case has a dif-
ferent origin. Mainstream smoke is the smoke that an
active smoker inhales with each puff, while sidestream
smoke, the main component of environmental tobacco
smoke, burns off the end of a lit cigarette and is the smoke
inhaled by passive smokers. While the association
between inhalation of mainstream smoke and cardiovas-
cular disease and cancer has been established for many
years, the impact of smoking on reproduction is recog-
nized, but less well characterized and less well known [1].
Epidemiological studies have repeatedly shown that
women of child bearing age who actively inhale main-
stream smoke have higher rates of infertility, spontaneous
abortion, ectopic pregnancy, tubal infertility, increased
time to conception, and intrauterine growth retardation
than nonsmokers [2-15]. Increases in infertility and
ectopic pregnancy in smokers could be due to impairment
of oviductal functioning. In patients with primary tubal
infertility, 39% were smokers when they started trying to
conceive in contrast to only 16% in the non-smoking
group (OR = 2.7) [10]. Heavy smoking (> 5 pack-years)
increased the odds ratio to 4.2, and similar dose related
effects have been repeatedly observed [11,16].
The realization that sidestream smoke exposure adversely
affects human health is even more recent [17]. In 1992,
the Environmental Protection Agency published a mono-
graph summarizing evidence that exposure to
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on cardiovascular and lung health and encouraged
broader investigation in this area [17]. Subsequently, a
number of studies have addressed the effect of passive
smoking on various aspects of human health including
reproduction and have concluded that adverse reproduc-
tive outcomes, such as delayed time to conception and
reduced birth weight, do occur as a consequence of expo-
sure to environmental tobacco smoke during pregnancy
[18-30]. Moreover, an in vitro fertilization lab recently
concluded that while fertilization rates and embryo qual-
ity were similar in smokers and non-smokers, implanta-
tion and pregnancy rates were adversely affected by both
active and passive smoking when compared to non-smok-
ing controls [31].
Recent reviews have addressed issues of cigarette smoke
exposure and various facets of reproduction including
delayed time to conception, ovarian effects and premature
menopause, implantation failure, fetal growth restriction
and growth retardation, placental abnormalities, reduced
fecundity, congenital abnormalities, and effects on male
reproduction [32-34]. However, most prior reviews have
not considered smoke's interaction with the oviduct, an
organ vital to reproduction. The purpose of this paper is
to review the functions of the oviduct, in particular those
that involve movement of gametes and embryos, and to
evaluate evidence that exposure to mainstream or side-
stream cigarette smoke can negatively impact oviductal
functioning and thereby adversely affect reproductive out-
comes. We will also consider evidence that commercial
cigarettes, including harm reduction and light cigarettes,
contain toxicants that impair oviductal functioning, and
we will discuss the specific chemicals in smoke that impair
oviductal functioning. Some of these chemicals adversely
affect oviductal processes at extremely low doses, are often
considered safe, and are added to cigarettes and other con-
sumer items.
B. Functions of the oviduct
The oviduct, which is divided anatomically into the
infundibulum, ampulla, and isthmus, plays important
roles in mammalian reproduction (Fig. 1) [35-41]. The
infundibulum is responsible for picking-up the oocyte
cumulus complex following ovulation and moving it into
the ampulla where fertilization occurs. Simultaneously,
the oviduct moves sperm in the opposite direction from a
reservoir near the uterotubal junction toward the ampulla
[42]. The oviduct also provides a suitable microenviron-
ment for capacitation of spermatozoa, fertilization, pre-
implantation development, and transport of the
preimplantation embryos to the uterus. The movement of
the embryo through the oviduct to the uterus is carefully
timed by ovarian hormones and signals from the embryos
[43]. While smoke exposure could affect any of these
processes, most current evidence links smoke to effects on
oocyte cumulus complex pick-up and embryo transport,
which will be reviewed in more detail in the following
sections.
(1) Oocyte cumulus complex pick-up by the infundibulum
The infundibulum is the portion of the oviduct closest to
the ovary and is responsible for picking up the oocyte
cumulus complex following its ovulation from a mature
ovarian follicle [44,45]. The oocyte cumulus complex
consists of a centrally located oocyte, which is in turn sur-
rounded by the zona pellucida, corona radiata, and cumu-
lus cells (Fig. 2) [46-48]. The complex contains 5,000–
8,000 cumulus cells, depending on the species, and these
are separated from each other by an extracellular matrix,
which plays an important role in the pick-up process. The
structure and distribution of the extracellular matrix
between cumulus cells has been well characterized in a
number of species including humans [46,49-52]. Bio-
chemically, the matrix is rich in hyaluronan (hyaluronic
acid) [53-55], which is cross-linked by inter-alpha trypsin
Schematic diagram showing the three anatomical regions of the oviduct (infundibulum, ampulla, and is h us) and the regi ns of he ovi uct here oocyt  cumulus complexes and pr mplantat on em ryos c n be foundFi ure 1
Schematic diagram showing the three anatomical regions of 
the oviduct (infundibulum, ampulla, and isthmus) and the 
regions of the oviduct where oocyte cumulus complexes and 
preimplantation embryos can be found. Oocyte cumulus 
complexes are ovulated from ovaries (#1), picked-up by the 
outer surface of the infundibulum (#2), and moved toward 
the ostium (unlabeled arrow) by ciliary beating then into the 
ampulla for fertilization (#3). Fertilized eggs and embryos are 
transported through the isthmus to the uterine cavity where 
they then can implant in the uterine wall.Page 2 of 17
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tumor necrosis factor-stimulated gene 6) also binds to
hyaluronan in the cumulus matrix [59-61]. The impor-
tance of these matrix components to reproduction is dem-
onstrated by the TSG-6 knockout mouse which fails to
assemble a cumulus matrix and is infertile [62].
Oocyte pickup by the infundibulum is a complex process
that involves both ciliary beating and adhesion between
the oviductal epithelium and the oocyte cumulus com-
plex [63-73]. Both the inner and outer surfaces of the
infundibulum are covered with ciliated epithelium (Fig.
3) [74]. Following ovulation, the oocyte cumulus com-
plex travels along the outer surface of the infundibulum
and enters the oviduct through the ostium (Fig. 3)
[45,75]. The complex then rapidly moves to the ampulla
where fertilization occurs. Although infundibular smooth
muscle may contract during the pick-up process, it does
not appear to be necessary for pick-up, which still occurs
when muscle contraction is inhibited with isoproterenol
[76].
Huang et al., developed an in vitro method for measuring
oocyte pickup rate using hamster infundibula [71]. At
room temperature, oocyte pickup rate averaged 55.2 +
10.6 um/sec and was dependent on the viscosity of the
culture medium and temperature. Moreover, complexes
were observed to move along particular pathways on the
surface of the infundibula depending on where they were
placed. This in vitro bioassay has subsequently evolved to
allow measurement of smooth muscle contraction [77]
and adhesion of the oocyte cumulus complex to the
infundibulum [72].
Schematic diagram of an oocyte cumulus complex after ovulation from an ovarian follicleFigure 2
Schematic diagram of an oocyte cumulus complex after ovulation from an ovarian follicle. The oocyte and polar body are con-
tained within the zona pellucida. Immediately outside the zona, cells are densely packed to form the corona radiata outside of 
which are numerous cumulus cells. The cumulus cells are widely separated from each other by spaces filled with an extracellu-
lar matrix (matrix is shown in Figure 5).Page 3 of 17
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analyze the process of pick-up in hamsters in conjunction
with video microscopy [45]. While small particles such as
Lycopodium spores can move over the infundibular surface
in the currents created by ciliary beating [45,78], the large
mass of the oocyte cumulus complex does not allow it to
move in the fluid currents created by ciliary beating alone.
In addition to ciliary beating, adhesion between the
cumulus cell matrix and the tips of the cilia is necessary to
move the complex over the surface of the infundibulum
[45,72]. The cumulus matrix attaches the complex to the
infundibulum, and as the cilia beat in the direction of the
ostium, the oocyte cumulus complex glides over the sur-
face of the infundibulum until it reaches and enters the
ostium. Figure 4 (Additional file 1) links to a video show-
ing the movement of a hamster oocyte cumulus complex
over the surface of an infundibulum. Additional videos of
this process can be viewed at http://www.talbotcen
tral.ucr.edu/oocytemovie.htm. In hamsters, the oocyte
cumulus complex is larger in diameter than the opening
of the ostium, and in order for the complex to enter the
oviduct, it goes through a "churning" process that com-
pacts the matrix between the cumulus cells making the
complex small enough to pass through the ostium [45].
During churning, the oocyte is sometimes squeezed from
the center of the complex to the periphery. Pick-up of a
human oocyte cumulus complex has been observed in
vivo using transvaginal hydrolaparascopy and involves
adhesion of the complex to the tumescent fimbria of the
infundibulum with ciliary beating drawing the complex
into the ostium [75].
Adhesion plays an essential role in the pick-up process
(Fig. 5) [66,72]. Oocytes denuded of cumulus cells are not
picked up [66], and when matrix is not secreted by the
cumulus cells, the complex fails to attach to the
infundibulum and it is not moved into the oviduct [72].
Polycationic compounds can block oocyte cumulus
Scanning electron micrograph showing a hamster oocyte cumulus complex, colorized blue, entering the ostium of an infu dibulumFigure 3
Scanning electron micrograph showing a hamster oocyte cumulus complex, colorized blue, entering the ostium of an infundibu-
lum. The outer and inner surfaces of the infundibulum are covered with cilia (inset).Page 4 of 17
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sion between the tips of the cilia and the complex [67].
Interestingly, peritoneal fluid from women with endome-
triosis contains a macromolecule (< 100,000 kDa) that
when assayed with hamster infundibula in vitro coats the
cilia on the surface of the infundibula and blocks adhe-
sion and hence pick-up of the human oocyte cumulus
complex by the hamster infundibulum [79,80]. Transmis-
sion electron microscopy revealed that adhesion during
complex pickup occurs specifically between the cumulus
matrix and the crowns at the tips of the infundibular cilia
[72]. An in vitro assay using vacuum from a low flow per-
istaltic pump has been developed to measure adhesion
between the oocyte cumulus complex and infundibulum
[72]. This assay was used to show that factors that either
increase or decrease adhesion can interfere with the pick-
up process. If the matrix of the oocyte cumulus complex is
made less sticky by compacting it or treating it with poly-
l-lysine, the complex cannot adhere tightly enough to the
infundibulum to be successfully picked up [72]. Con-
versely, if adhesion is increased, for example by treating
complexes or the oviduct with the lectin wheat germ
agglutinin, ciliary beating is not strong enough to tran-
siently detach the complex and move it to the ostium.
Thus successful pick-up requires a delicate balance
between proper strength of adhesion of the complex to
the infundibulum and ciliary beating towards the ostium.
The ampulla serves as a reservoir for the oocyte cumulus
complex, and hormonally controlled oviductal secretions
play an important role in creating a suitable microenvi-
ronment for fertilization and initial preimplantation
development [37,44,81,82]. After entering the female
reproductive tract, sperm are stored in a reservoir near the
uterotubal junction [42]. As some sperm leave the reser-
voir and move through the isthmus of the oviduct, they
become fully capacitated and their motility becomes
hyperactivated [38,83,84]. Hyperactivation is thought to
be critical to fertilization as it allows sperm to detach from
the oviductal epithelium, move in the lumen of the ovi-
duct, and penetrate through the extracellular matrices
surrounding the oocyte [84]. Sperm meet the oocyte
cumulus complex in the ampulla where fertilization nor-
mally occurs, and after fertilization, the preimplantation
embryo undergoes cleavage as it is transported through
the ampulla and the isthmus to the uterus for implanta-
tion [47]. Movement through the ampulla may involve
both ciliary beating and smooth muscle contraction.
When sections of the ampulla were surgically reversed in
their orientation, few rabbits became pregnant [85]. In
cases where pregnancy did occur, muscle contraction
apparently overcame ciliary beating toward the ovary,
showing that the cilia in the ampulla normally play an
important role in controlling movement into the isthmus
[85]. The isthmus of the oviduct is essential for normal
reproduction, as its removal results in infertility [86].
(2) Transport of preimplantation embryos to the uterus
A number of factors can influence the transport of preim-
plantation embryos through the ampulla and isthmus of
the oviduct. Interestingly, the oviduct can distinguish
between unfertilized oocytes and preimplantation
embryos. which are transported at different rates, with
embryos reaching the uterus one day earlier than unferti-
lized oocytes [87]. The production by embryos of platelet-
activating factor (PAF), which mediates signaling to the
oviduct, accelerates the passage of preimplantation
embryos, but not oocytes, through the oviduct [88]. PAF
may affect transport by increasing ciliary beating [89].
Human embryos likewise release PAF in vitro, and human
oviducts synthesize both the PAF receptor and PAF acetyl-
hydrolase, which degrades PAF, further supporting a role
for PAF in the embryo-oviductal dialogue [90]. When rat
embryos of different ages were transferred to the oviduct
of pregnant females, older embryos reached the uterus
before younger ones, again suggesting differential trans-
port rates of embryos that depend on age [91]. These data
from hamsters and rats support the idea that embryo
transport is at least, in part, subtly controlled by the
Micrograph showing a hamster oocyte cumulus complex, stained blue, on the outer urface of an infundibuluFigure 4
Micrograph showing a hamster oocyte cumulus complex, 
stained blue, on the outer surface of an infundibulum. Click 
the link to view a video of this complex being picked up by 
the oviduct. Reprinted from Molec Biol Cell 10:5–9, 1999 
(with permission). See also http://www.rbej.com/imedia/
2132055580757722/sup1.movPage 5 of 17
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and parity also influence embryo transport [92]. In ham-
sters, transport to the uterus occurred faster in young nul-
liparous females than in nulliparous or multiparous adult
females. In the group of young females, but not the adults,
development of the embryos was also highly
synchronous.
Transport of preimplantation embryos through the ovi-
duct is accomplished by smooth muscle contraction and
ciliary beating [76,93]. However, the relative
contributions of these two processes are not yet
completely understood, and it is probable that both play
roles in transport. The ampulla and isthmus are both
lined by ciliated cells, which beat in the direction of the
uterus [76]. The relative number of cilia decreases and the
thickness of the muscle layers increases proceeding
toward the uterine end [94], suggesting that cilia become
relatively less important in the isthmus. Muscle contrac-
tion produces oscillating movements in the isthmus
[64,95,96] that result in a net transport of preimplanta-
tion embryos towards the uterus [97]. Nitric oxide syn-
thase inhibitors increased muscular activity in rats, and
this was accompanied by increased rate of movement of
eggs or microspheres in the oviduct [97]. These data sup-
port the idea that that muscle contraction can modulate
(speed or slow) transport through the oviduct. Muscle
contractions may also be important in keeping embryos
grouped together as they are transported through the isth-
mus [98].
Muscle contraction in the oviduct is regulated by a variety
of factors; however, the interplay of these factors with
each other is not yet well understood. The oviductal mus-
cles are innervated by the sympathetic nervous system
[99,100]. Stimulation of α adrenergic receptors promotes
contraction of the oviductal muscles, while stimulation of
β receptors inhibits contractions [100-102]. Alternating
contraction and relaxation produce the oscillatory
movements involved in embryo transport. However, the
adrenergic neurons may not be the primary means for
controlling embryo transport since experimental deple-
tion or inhibition these neurons does not prevent trans-
port nor decrease fertility [35]. Chemicals produced by
the oviduct itself or the preimplantation embryo can also
modulate muscle contraction and may play the lead role
Micrographs showing adhesion between the oocyte cumulus complex and the infundibulumFigure 5
Micrographs showing adhesion between the oocyte cumulus complex and the infundibulum. (A) Stereoscopic micrograph of an 
oocyte cumulus complex, colorized blue, being pulled off the surface of an infundibulum using forceps. The matrix of the com-
plex adheres to the infundibulum. Complexes do not adhere to most other surfaces. (B) Scanning electron micrograph of 
cumulus matrix adhering to cilia on the outer surface of an infundibulum. The matrix was left behind by an oocyte cumulus 
complex that was picked-up by the infundibulum.Page 6 of 17
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steroids and prostaglandins. Endogenous estrogens stim-
ulate oviductal muscle contraction, while progesterone
relaxes it [103]. Likewise the prostaglandins PGF and PGE
contract and relax oviductal muscle respectively [104-
106]. Human oviduct smooth muscle also produces the
prostaglandin prostacyclin which decreases muscle con-
tractility and may affect embryo transport [107]. Oviduc-
tal smooth muscle also contains a nitric oxide system
[108] that promotes muscle relaxation [109]. Inhibition
of nitric oxide syntheses in rats increases oviductal motil-
ity and results in accelerated movement of embryos
through the oviduct [97]. In additions to prostaglandins,
the oviduct produces, endothelin-1 [110] and angiotensin
II [111] which are involved in modulating oviductal mus-
cle contraction and regulation of embryo transport.
Recent data from the cow suggest that tumor necrosis fac-
torα from the oviductal epithelium, immune cells of the
oviduct, or even the embryo itself stimulates the release of
these effectors from the oviductal epithelial cells [111]. A
newly uncovered transport regulatory mechanism
involves the cannabinoid receptor CB1 [112]. When CB1
is genetically or pharmacologically silenced, embryos are
retained in the oviduct. This effect can be reversed by iso-
proterenol, a β adrenergic agonist. These data suggest that
cannabinoid signaling is important in coordinating ovi-
ductal muscle contraction, and is necessary for proper
embryo transport. While this review deals with conven-
tional cigarette exposure, these results with the CB1 recep-
tor suggest that exposure to marijuana for either
recreational use or pain relief could affect embryo trans-
port and hence female fertility. It is clear from the preced-
ing that the regulation of embryo transport through the
oviduct is complex and may depend on multiple regula-
tory mechanisms, some of which are just now being
identified.
(3) Biological importance of pick-up and transport by the 
oviduct
Timing of oocyte pick-up and embryo transport is critical
as the preimplantation embryos must arrive in the uterus
during the window when implantation can occur
[113,114]. If the oocyte is not picked up by the oviduct or
if the embryo moves through the oviduct too quickly or
too slowly, implantation may fail to occur or may be
ectopic. In rats, embryo transport was accelerated by treat-
ment with methoxychlor, an estrogenic pesticide, and the
embryos failed to implant in the uterus [115]. Likewise
women treated with ergonovine maleate, a powerful stim-
ulant of oviductal contraction, showed decreased concep-
tion rates when the drug was delivered immediately post
coitus [116]. Interference with embryo transport can
adversely affect fertility and in humans lead to ectopic
implantation.
C. Evidence that the oviduct is a target of 
cigarette smoke
While epidemiological studies have been clear in identify-
ing increased reproductive risks for women who smoke
both actively and passively (Section A), the reasons that
smoke causes reproductive problems are usually not
understood. Some of the risk factors for women smokers,
such as ectopic pregnancy, failure to conceive, increased
time to conception, could be due to effects of smoke on
the pick-up and transport by the oviduct. We will next
examine the in vivo and in vitro evidence supporting the
idea that the oviduct is targeted by cigarette smoke.
(1) In vivo evidence that the oviduct is a target of smoke
Direct inhalation of whole smoke has been shown in sev-
eral studies to adversely affect the oviduct. Oviductal
motility is altered in humans [117] and in rabbits [118]
by inhalation of mainstream smoke. Inhalation of main-
stream or sidestream smoke by hamsters, at serum coti-
nine levels that were within the ranges found in active and
passive human smokers (mainstream = 72.8 and
sidestream = 14.9 ng cotinine/mL) produced blebbing of
the oviductal epithelium at the ultrastructural level and
decreased the ratio of ciliated to secretory cells in the
ampulla [119]. In a related study on hamsters, inhalation
of either mainstream or sidestream smoke at levels that
produced serum cotinine levels equivalent to those in
human smokers (mainstream = 50–250 and sidestream =
18–80 ng cotinine/ml) slowed preimplantation embryo
transport through the oviduct [120]. In addition, muscle
contractions of the ampulla were significantly inhibited in
vivo during smoke exposure, supporting the conclusion
that embryo transport rates were slowed by inhibition of
smooth muscle contraction [120]. While smooth muscle
contraction rates did increase after smoke exposure
stopped, they did not return to control levels, showing
that inhibition of contraction by smoke is not immedi-
ately completely reversible.
Several in vivo studies using animal models have estab-
lished that the oviduct is a target of nicotine, a major con-
stituent of cigarette smoke. When administered to mice in
drinking water, nicotine (108 µmol/L) significantly
decreased Na and K ion concentrations in the oviductal
epithelium [121]. In addition, nicotine injected subcu-
tanenously (2.5 mg twice daily) into rats produced a sig-
nificant increase in lactate dehydrogenase levels in
flushings of the oviduct in early pregnancy [122]. While a
change in the ionic composition of the oviductal epithe-
lium or its secretions might adversely affect adhesion of
the oocyte to the oviductal surface and the oocyte pick-up
process, the relationship between these nicotine-induced
changes and oviductal functioning has not yet been estab-
lished experimentally. Nevertheless, these studies doPage 7 of 17
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52demonstrate that nicotine exerts effects on the oviductal
epithelium.
Two additional studies on rats indicate further effects of
nicotine on oviductal functioning. When pregnant rats
were treated with pharmacological doses of nicotine (2.5
mg injected subcutaneously twice daily), preimplantation
embryo transport was inhibited [123]. In addition, nico-
tine (5 mg/kg), when injected subcutaneously twice daily
in pregnant rats, both retarded embryonic development
and reduced blood flow to the oviduct [124]. Reduction
of oviductal blood flow decreases smooth muscle contrac-
tion, which in turn can delay embryo transport [124,125].
In other studies, nicotine slowed oviductal contraction in
vivo in the Rhesus monkey, which may prevent implanta-
tion [126]. Oral nicotine administration through drinking
water (108 µmol/L) also interfered with oocyte matura-
tion, fertilization, and early pregnancy in mice [121]. Col-
lectively these data show that nicotine affects the
composition and secretions of the oviductal epithelium,
adversely affects preimplantation development, retards
movement of embryos through the oviduct, and reduces
blood flow to this organ.
In a study involving gamete intrafallopian transfer (GIFT),
no differences were found among active, passive and non-
smokers in number of oocytes retrieved; however the
number of live births after GIFT was significantly lower for
active smokers (10.5%) than for passive smokers (23.1%)
or non-smokers (33.3%) smokers [127], which could
indicate an effect of smoke on the human oviduct.
Taken together these in vivo studies demonstrate that the
oviduct responds to exposure to both whole mainstream
and sidestream smoke and to nicotine and that the trans-
port of preimplantation embryos can be inhibited by cig-
arette smoking, apparently by an inhibition of oviductal
smooth muscle contraction. In vivo studies have not yet
been undertaken to determine if oocyte cumulus complex
pick-up is slowed in smoke exposed animal models or
humans.
(2) In vitro evidence that smoke affects oviductal 
functioning
In vitro models have facilitated studies on smoke's effect
on the oviduct and have further supported the conclusion
that the oviduct is responsive to chemicals in cigarette
smoke (Fig. 6, additional file 2). A hamster infundibular
explant model [71] has been used to simultaneously
measure ciliary beat frequency, adhesion, oocyte pick-up
rate, and muscle contraction, before, during, and after
exposure to smoke or its constituents [70,128-133]. In
general, in vitro studies show that mainstream and side-
stream smoke solutions adversely affect proper function-
ing of the oviduct. Mainstream and sidestream smoke
solutions made from University of Kentucky 2R1 research
cigarettes in a medium lacking bovine serum albumin
(BSA) inhibited ciliary beat frequency in a dose depend-
ent manner [128]. When BSA was included in the
medium, mainstream solutions continued to inhibit beat
frequency, while sidestream solutions either had no effect
or slightly stimulated beat frequency, suggesting that the
presence of BSA influenced how sidestream smoke
affected beat frequency [129]. Interestingly, in both main-
stream and sidestream solutions containing BSA, oocyte
pickup rate was inhibited in a dose-dependent manner
with sidestream smoke often being more inhibitory than
mainstream smoke (Fig. 6). Since ciliary beat frequency
was either not affected or slightly stimulated in sidestream
smoke, these data show that smoke can inhibit oocyte
pick-up rate by affecting factor(s) other than ciliary beat
frequency. Oocyte pickup rate was more sensitive to the
gas than the particulate phase of mainstream and side-
stream smoke solutions [129].
Since pick-up rate decreased in sidestream smoke when
beat frequency increased, oocyte pick-up rate must
depend on factor(s) other than ciliary beat frequency
[129]. Since adhesion of the oocyte cumulus complex to
the tips of the cilia is important in oocyte pick-up
[66,68,72], the effect of smoke solutions on adhesion was
measured in vitro using the hamster infundibular model.
Both mainstream and sidestream solutions inhibited
oocyte cumulus complex pick-up rate and increased
adhesion of the cumulus to the oviduct [133]. As was
shown previously using wheat germ agglutinin [72],
increasing adhesion by exposure to smoke leads to a
decrease in pick-up rate since the complex can not be
moved by the cilia if it adheres too tightly to the oviduct.
These effects on adhesion and pick-up rate were observed
when only the oocyte cumulus complex was pretreated
with smoke solution or when only the infundibulum was
pretreated, indicating that both the cumulus matrix and
oviduct are targets of smoke treatment [133]. The oviduct
was more sensitive to treatment than the oocyte cumulus
complex, perhaps because smoke pretreatment affected
both ciliary beat frequency and adhesion of infundibula
but only adhesion of oocyte cumulus complexes. These
data indicate that factors that increase adhesion of the
oocyte cumulus complex to the cilia can decrease pick-up
rate and explain why both mainstream and sidestream
smoke solutions decrease pick-up rate even when ciliary
beat frequency is increased by treatment with sidestream
smoke.
The above studies were all done using non-filtered 2R1
research brand cigarettes manufactured at the University
of Kentucky. A subsequent study examined the effects on
oviductal functioning of smoke solutions from a filtered
research brand cigarette (1R4F), various traditionalPage 8 of 17
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Red, Marlboro Light, Camel filtered, Camel unfiltered,
Kool, and Kool with the filter removed), and three brands
of harm reduction cigarettes (Advance, Omni and Omni
Light) [134]. Harm reduction cigarettes have recently
been introduced commercially and are claimed to contain
fewer carcinogens than traditional commercial brands
[135]. All of the cigarettes tested (research, traditional
commercial, harm reduction) adversely affected oviductal
functioning, and the effects were in general stronger on
oocyte pick-up rate and smooth muscle contraction than
on ciliary beating. Sidestream smoke generally produced
a stronger effect in all assays than mainstream smoke solu-
tion. Smoke from the 1R4F cigarettes, which more closely
resemble the commercial brands smoked today than the
2R1 cigarettes, was considerably more inhibitory in the
pick-up rate and muscle contraction assays than the 2R1s.
Except for mainstream smoke from Marlboro Lights and
Kools, all traditional brand smoke solutions reduced pick-
up rate by more than 60%. Except for mainstream smoke
from Marlboro Lights and Camel filtered, all smoke solu-
tions from traditional brands reduced muscle contraction
by more than 80%. Smoke from harm reduction cigarettes
reduced pick-up rate by 50–80% and reduced muscle con-
traction by 30–98% depending on the type of smoke and
brand. These data show that the adverse effects observed
on oviducts with 2R1 research cigarettes are also produced
by filtered research cigarettes and by filtered, non-filtered
and light commercial brands. Moreover, harm reduction
cigarettes, while reduced in levels of carcinogens, still con-
tain toxicants that can impair oviductal functioning.
Pick-up rate could also be altered by action of smoke on
the oocyte cumulus complex, in particular the matrix
which is required for adhesion to the cilia [72]. Both
mainstream and sidestream smoke solutions from 2R1
cigarettes caused more dispersal of hamster cumulus cells
during in vitro incubation than control medium lacking
smoke, and oocyte pick-up rate was slowed when oocyte
cumulus complexes were pretreated with smoke prior to
measuring pick-up rate [133]. In addition,in vitro expo-
sure of porcine oocyte cumulus complexes to nicotine,
cadmium, and anabasine, all components of cigarette
smoke, suppressed FSH induced expansion of the cumu-
lus and decreased synthesis and accumulation of
hyaluronic acid in the cumulus matrix [136]. These stud-
ies show that the matrix of the oocyte cumulus complex is
also a target of cigarette smoke and damage to the matrix
can affect pick-up of complexes by the oviduct.
D. What chemicals in cigarette smoke impair 
oviductal functioning?
(1) Chemicals most studied in smoke
Cigarette smoke is a complex suspension that contains
over 4,000 chemicals distributed between a gaseous and
particulate phase [17]. Most studies on cigarette smoke
and its components have focused on nicotine [137-139],
carcinogens [140,141], polycyclic aromatic hydrocarbons
(PAHs) [142-144], such as benzo-a-pyrene, tobacco-spe-
Micrographs showing oocyte cumulus complex pick-up by a hamster infundibulum of a control (6B) and a sidestream smoke treated (6A) preparati nFigure 6
Micrographs showing oocyte cumulus complex pick-up by a hamster infundibulum of a control (6B) and a sidestream smoke 
treated (6A) preparation. Click the link to view a video of this experiment. During approximately 10 seconds of observation, 
the control complex moves toward the ostium while the smoked treated complex does not move. Reprinted from Molec Biol 
Cell 10:5–9, 1999 (with permission). See also http://www.rbej.com/imedia/1622614392757722/sup2.movPage 9 of 17
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LOAELs (M)2
CHEMICALS Oocyte Ciliary Beat Contraction FEMA FDA ADDED5
Pick-up Rate Frequency Rate GRAS3 EAFUS4
PYRIDINES
2-ethylpyridine 9.35 × 10-12 9.35 × 10-12 9.35 × 10-12
4-methylpyridine 9.50 × 10-11 9.50 × 10-11 9.50 × 10-11
2-methylpyridine 9.35 × 10-11 9.35 × 10-11 9.35 × 10-10
4-ethenylpyridine 9.30 × 10-11 9.30 × 10-9 9.30 × 10-11
3-ethylpyridine 9.33 × 10-10 9.33 × 10-11 9.33 × 10-10 √ √ √
Nornicotine 6.85 × 10-9 6.85 × 10-8 6.85 × 10-8
beta-nicotyrine 6.33 × 10-9 6.30 × 10-8 X6
2,4,6-trimethylpyridine 8.25 × 10-8 8.25 × 10-6 8.25 × 10-8
2,4-dimethylpyridine 9.34 × 10-7 X6 9.34 × 10-9
2,3-dimethylpyridine 9.34 × 10-7 9.34 × 10-7 X6
4,4-bipyridine 8.78 × 10-6 8.78 × 10-7 8.78 × 10-4
2,5-dimethylpyridine 9.34 × 10-5 X6 9.34 × 10-5
3,4-dimethylpyridine 1.76 × 10-5 X6 1.76 × 10-4
pyridine 1.27 × 10-5 1.27 × 10-3 1.27 × 10-3 √ √ √
3-methylpyridine 1.23 × 10-5 Xd 1.23 × 10-2
2,2-bipyridine 8.74 × 10-4 8.74 × 10-2 8.74 × 10-2
cotinine 2.84 × 10-2 2.84 × 10-5 X6
nicotine 9.01 × 10-2 X6 6.70 × 10-2
PYRAZINES
2-methoxy-3-methylpyrazine 10-12 10-9 10-12
pyrazine 10-11 10-12 10-9 √ √
2-methylpyrazine 10-11 10-12 10-11 √ √ √
2-ethylpyrazine 10-11 10-12 10-12 √
2,5-dimethylpyrazine 10-11 10-8 10-9 √ √ √
2,3,5-trimethylpyrazine 10-10 10-9 10-9 √ √ √
2,6-dimethylpyrazine 10-9 10-6 10-7 √ √ √
PHENOLS, INDOLES, OTHERS
Indole 10-14 10-13 10-15 √
Isoquinoline 10-13 10-12 10-13 √
4-Ethylphenol 10-12 10-11 10-12 √ √
Quinoline 10-11 10-13 10-11 √
4-Methylphenol 10-11 10-12 10-11 √ √
2-Methylphenol 10-11 10-9 10-11 √ √
5-Methylindole 10-11 10-10 10-10
2,6-Dimethoxyphenol 10-11 10-10 10-9 √
Hydroquinone 10-10 10-10 10-10
3-Methyl-2-cylcopenten-1-one 10-10 10-7 10-10
2,4-Dimethylphenol 10-10 10-9 10-9
2-Methoxyphenol 10-10 10-8 10-8
2-Cyclopenten-1-one 10-9 10-7 10-9
4-Methoxyphenol 10-8 10-7 10-7
2-Ethylphenol 10-8 10-5 10-7
2,5-Dimethylphenol 10-7 10-8 10-6
Benzene 10-7 10-8 10-6
Phenol 10-2 10-1 10-2 √
1Compiled from References 131, 132, and 135.
2LOAEL = Lowest observed adverse effect level in the oocyte pick-up rate, ciliary beat frequency, and muscle contractions assays.
3Chemicals known to be on the FEMA GRAS list. Others may also be on this list.
4Chemicals on the FDA EAFUS list (Everything Added to Food in the United States).
5Chemicals that are added to cigarettes by American tobacco companies.
6No effect at the highest dose tested.Page 10 of 17
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[147,148], tar [149-151], metals (cadmium, lead)
[152,153], and ten to fifteen other compounds including,
phenol, acrolein, acetaldehyde, hydrogen cyanide, and
formaldehyde [17,154-164]. Most of these chemicals
have been linked to cancer or cardiovascular and lung dis-
ease. Of the 4,000 compounds found in cigarette smoke,
at least 50 are known carcinogens [141]. PAHs and
tobacco-specific N-nitrosamines are major contributors to
lung cancer [154,161,165,166], while tar and carbon
monoxide are major contributors to cardiovascular dis-
ease and chronic obstructive lung diseases [161,163,167].
PAHs have also been shown to initiate or promote athero-
sclerosis in avian [168-170] and mammalian [171] mod-
els. The PAH benzo(a)pyrene, induces atherosclerosis by
stimulating proliferation of vascular smooth muscle cells
that migrate into the vessel lumen [172,173].
(2) Chemicals in smoke that affect the oviduct
Most of the above-mentioned chemicals that are com-
monly studied in smoke have not been studied with
respect to their effects on the oviduct. An exception is nic-
otine, which did alter oviductal epithelium secretion and
ion composition, embryo transport, embryo develop-
ment, and oviductal blood flow in several in vivo studies
(Section C1) and cumulus expansion in vitro [136].
(a) Ciliotoxic chemicals
Numerous studies have shown that cigarette smoke con-
tains chemicals that are toxic to cilia of the mammalian
respiratory system [174-178], the amphibian palate [179],
Paramecium [180,181], and the gills of mussels, clams,
and mollusks [182,183]. Moreover, nicotine increased cil-
iary beat frequency in the ferret trachea [184], formalde-
hyde inhibited respiratory cilia in the rabbit and pig
[185]; and hydrogen cyanide, acrolein, and acetaldehyde
inhibited ciliary beating in the clam [182]. Using an in
vitro infundibular bioassay, the individual smoke constit-
uents, which had been previously shown to be ciliotoxic
in non-oviductal systems [175,176,182], were tested spe-
cifically for their effect on oviductal cilia [186]. Potassium
cyanide (KCN), acrolein, phenol, acetaldehyde, and for-
maldehyde all inhibited ciliary beat frequency in a dose
dependent manner in vitro [186]. However, only KCN was
present in cigarette smoke solutions in a high enough con-
centration to account for the effect seen in vitro. KCN also
inhibited oocyte pick-up rate. Nicotine did not inhibit cil-
iary beat frequency of the hamster oviduct, except at
extremely high doses (Talbot, unpublished data).
(b) Pyridines, pyrazines, and phenols
Since cigarette smoke contains over 4000 compounds
[17], there are likely other chemicals present in main-
stream and sidestream cigarette smoke that can adversely
affect oviductal functioning. To identify such chemicals,
mainstream smoke solution from 2R1 cigarettes was
fractionated by passage through 12 different solid phase
extraction cartridges [77]. The eluates from each cartridge
were screened using the hamster infundibular bioassay,
and three cartridges were identified that retained inhibi-
tory activity in the ciliary beat frequency, oocyte pick-up
rate, and smooth muscle contraction bioassays. The
chemicals in the eluates of each cartridge were then iden-
tified using GC-MS, and authentic standards of the identi-
fied compounds were purchased from commercial
sources and tested independently to determine their activ-
ity in each of the three infundibular bioassays.
Pyridines, pyrazines, and phenols were the three major
groups of chemicals identified in the inhibitory eluates
(Table 1) [77,131,132]. Several other types of compounds
including quinolines, indoles, and cyclopenten-1-ones
were also present [132]. Within all groups, chemicals were
identified that were highly inhibitory in all three bio-
assays, and some of the chemicals had LOAELs (lowest
observed adverse effect levels) in the nano, pico and
femtomolar range (Table 1). In general, if a chemical were
inhibitory, it acted in all three bioassays, although the
potency and efficacy for a particular chemical varied
among the assays. Some of the compounds that were
identified in this screen (Table 1) were previously thought
to be safe and are included on the FEMA GRAS list (Flavor
and Extract Manufacturers' Association – Generally
Regarded As Safe) and the FDA EAFUS list (Everything
Added to Food in the United States). Some of these
chemicals are added to tobacco to flavor it (Table 1). For
example, 3-ethylpyridine, which was inhibitory in all
three bioassays at picomolar doses, is on the list of 599
chemicals added to tobacco in the United States [187]. Of
the seven pyrazines tested, six are on the FDA EAFUS list,
and in all but three assays, the pyrazines had LOAELs in
the nanomolar or picomolar range. Indole and isoquino-
line were the most toxic of all chemicals tested with
LOAELs in the femtomolar range, except for isoquinoline
which had a picomolar LOAEL in the ciliary beat fre-
quency assay.
Many of the compounds in Table 1 were also screened
using a chick chorioallantoic membrane (CAM) assay that
measures growth of the CAM and chick embryo
[188,189]. In the CAM assay, many pyridines and pyra-
zines inhibited CAM growth dramatically, even at very
low doses, and in some cases they also inhibited embryo
growth. It is interesting that the chemicals in Table 1 were
inhibitory in assays that measure diverse biological proc-
esses (ciliary beat frequency, oocyte pick-up, smooth
muscle contraction, growth). It is not yet known if inhibi-
tion occurs by distinct mechanisms or if a basic underly-
ing mechanism, such as inhibition of ATP production,
was affected. Nor is it known if the chemicals act directlyPage 11 of 17
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of some of the chemicals, activation of a signaling cascade
is possible.
These data from the oviduct and CAM studies indicate a
need for further toxicological testing on the chemicals in
Table 1, especially since some of them are used routinely
in consumer products including food, cigarettes and cos-
metics. These data also indicate a need for additional stud-
ies on the chemicals in smoke in general. The solid phase
cartridge screen found about 40 oviductal toxicants, most
of which were not previously recognized as smoke toxi-
cants. It is probable that there are other toxicants in ciga-
rette smoke that have not yet been identified as harmful
nor studied in detail.
E. Concentrations of smoke toxicants in 
cigarettes and in human smokers
The data on oviductal toxicants beg the question – what
are the concentrations of these compounds in cigarette
smoke and in actual active and passive smokers? Some of
the oviductal toxicants, such as nicotine, have been stud-
ied extensively, and concentrations are well documented
in both cigarettes and smokers [17,190-192]. The LOAEL
concentrations of 2-ethylpyridine, 2-methylpyridine, and
3-ethylpyridine are about 10,000 to a million times lower
than the concentration of these chemicals in mainstream
and sidestream smoke from commercial cigarettes and
cigars [77,193]. However, some of these toxicants, such as
3-ethylpyridine, have not previously been recognized as
harmful, and little is known about their concentrations, in
smokers. Many chemicals were inhibitory in the infundib-
ular bioassays at nano and picomolar doses suggesting
that they could be effective in vivo at extremely low doses
that would be difficult to detect and measure.
Concentrations of cigarette smoke components, such as
phenolic compounds, vary among different brands of cig-
arettes [194]. For example, different types of cigarettes,
such as Indian Bidi cigarettes, have higher concentrations
of phenols than traditional commercial cigarettes [157].
Concentrations of chemicals also vary between various
research brand cigarettes [195]. Finally, the source of the
smoke also affects chemical concentration. While main-
stream and sidestream smoke have similar chemicals the
relative amounts of particular chemicals can vary signifi-
cantly between the two types of smoke [17].
Cigarette smoke chemicals or their metabolites must gain
access to the circulatory system and reach their target
organs to exert their toxicity. Studies have measured nico-
tine, cotinine (a metabolite of nicotine), and other ciga-
rette smoke components in reproductive tissues, although
little is known about concentrations in the oviduct per se.
Interestingly, levels of cigarette toxicants in reproductive
tissues or fluids can be significantly higher than in serum.
For example, pregnant rabbits injected with tritiated nico-
tine had 5–11 times higher nicotine concentrations in
uterine fluid than in plasma [196]. Both nicotine [197]
and phenols [198] have been detected in the cervical fluid
of smokers, and nicotine concentrations in the cervical
fluid (66–2620 ng/ml) were significantly higher than in
serum (0.1–39 ng/ml) [199].
Cigarette smoke components have also been detected in
the follicular fluid of smokers [200,201]. Cotinine, a
biomarker for smoke exposure, was higher in the follicu-
lar fluid of active smokers (mean = 285.69 ng/ml; range =
62.21–595.00) than passive smokers (mean = 29.65 ng/
ml; range = 20.91–45.75) and nonsmokers (mean = 3.71
ng/ml; range = 1.20–15.62) [200]. Cadmium, like other
smoke components, does reach and accumulate in the
follicular fluid of smokers (7.93 ng/mL) [202], and cad-
mium concentration in the ovary was elevated in smokers
(150 ng/g) versus nonsmokers (115 ng/g) [203]. While
cadmium apparently does not interfere with embryo
transport through the oviduct in the rat [204], it is another
example of a smoke toxicant that can accumulate in repro-
ductive organs and which, in laboratory animals, can
adversely affect reproduction [205]. While many of the
toxicants that affect the oviduct have not been quantified
in smokers and there is little known about their concen-
trations in the oviduct, those chemicals that have been
studied, appear to reach the reproductive organs and are
often found in higher concentration in reproductive tis-
sues and fluids than in serum or urine.
F. Summary
The oviduct, while seemingly a simple organ, is exqui-
sitely designed to convey gametes in opposite directions
virtually simultaneously and to provide a suitable envi-
ronment for preimplantation development and transport
of embryos to the uterus for implantation. It is vital for
reproductive success. Factors that interfere with its func-
tioning can adversely affect fertility. The oviduct serves as
a useful model to evaluate the effect of cigarette smoke
and its components on a reproductive organ and in a
more general sense on a variety of biological functions.
While most work on smoke's effect on the oviduct has
been done on ciliary beat frequency, oocyte pick-up rate,
cilia-oocyte cumulus complex adhesion, and smooth
muscle contraction, other parameters of oviductal func-
tioning could be added to this array of bioassays. For
example, monitoring the synthesis and secretion of the
oviductal proteins may give further insight into how
smoke affects oviductal functioning and secretory proc-
esses in general. The oviductal assays have been useful in
identifying numerous smoke toxicants many of which
were not previously recognized as harmful and some of
which are widely used in consumer products. Further
studies on the safety of these chemicals are needed. Com-Page 12 of 17
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shutting down oviductal functions in vitro and interest-
ingly sidestream smoke is often more inhibitory than
mainstream smoke. Harm reduction cigarettes, while
apparently reduced in carcinogens, still contain chemicals
that impair basic biological processes including ciliary
beating, oocyte pick-up, and smooth muscle contraction.
The effects of smoke on the heart and lungs is widely
known and well documented. The effects of smoke on the
oviduct, which are just recently becoming more widely
recognized, demonstrate that organs remote from the site
of inhalation may be adversely affected by chemicals in
smoke are consistent with the idea that all organs are tar-
gets of smoke [1]. Active and passive smokers of reproduc-
tive age should be made aware of the possible dangers in
smoking and how smoking could affect their reproductive
ability.
Additional material
Acknowledgements
We gratefully acknowledge the Tobacco-Related Disease Research Pro-
gram of California which supported parts of the work reviewed in this arti-
cle and our many associates who helped conduct the work. We are also 
grateful to Dr. Ray Talbot for his help in preparing the table.
References
1. The Health Consequences of Smoking: a Report of the Sur-
geon General.  Atlanta, GA, Dept of Health and Human Services,
Center for Disease Control, antional Center for Chronic Disease
Preventation and Health Promotion, Office of Smoking and Health,
Washington, DC; 2004. 
2. Stillman RJ, Rosenberg MJ, Sachs BP: Smoking and Reproduction.
Fertil and Sterility 1986, 46:545-566.
3. Atrash HK, Hughes JM, Hogue C: Ectopic pregnancy in the
United States, 1970-1983.  CDC Surveillence Summaries MMWR
1986, 35:29-37.
4. Stergachis A, Scholes D, Daling JR, Weiss NS, Chu J: Maternal cig-
arette smoking and the risk of tubal pregnancy.  Am J
Epidemiology 1991, 133:322-337.
5. Augood C, Duckitt K, Templeton AA: Smoking and female infer-
tility: a systematic review and meta-analysis [see
comments].  Hum Reprod 1998, 13:1532-1539.
6. Saraiya M, Berg CJ, Kendrick JS, Strauss LT, Atrach HK, Ahn YW:
Cigarette smoking as a risk factor for ectopic pregnancy.  Am
J Obstet Gynecol 1998, 178:493-498.
7. Shiverick KT, Salafia C: Cigarette smoking and pregnancy I:
ovarian, uterine and placental effects.  Placenta 1999,
20:265-272.
8. Bouyer J: [Epidemiology of ectopic pregnancy: incidence, risk
factors and outcomes].  J Gynecol Obstet Biol Reprod (Paris) 2003,
32:S8-17.
9. Burguet A, Agnani G: Smoking, fertility and very preterm birth.
Journal of Gynecology and Obstetric Biology of Reproduction 2003,
32:1S9-16.
10. Daling JR: Cigarette smoking and primary tubal infertility.  In
Smoking and Reproductive Health Edited by: MJ R. Littleton, MA, PSG
Publishers; 1987:40-46. 
11. Phipps WR, Cramer DW, Schiff I, Belisle S, Stillman R: The associa-
tion between smoking and female infertility as influenced by
cause of infertility.  Sterility and Fertility 1987, 48:377-382.
12. Chow WH, Daling JR, Weiss NS: Maternal cigarette smoking
and tubal pregnancy.  Obstetrics and Gynecology 1988, 71:167-170.
13. Wald NJ, Hackshaw AK: Cigarette smoking: an epidemiological
overview.  Br Med Bull 1996, 52:3-11.
14. Munafo M, Murphy M, Whiteman D, Hey K: Does cigarette smok-
ing increase time to conception?  J Biosoc Sci 2002, 34:65-73.
15. Dekeyser-Boccara J, Milliez J: [Smoking and ectopic pregnancy:
is there a causal relationship?].  J Gynecol Obstet Biol Reprod (Paris)
2005, 34 Spec No 1:3S119-23.
16. Baird DD, Wilcox AJ: Cigarette smoking associated with
delayed conception.  Jama 1985, 253:2979-2983.
17. EPA: EPA Report/600/6-90/006F: Respiratory health effects of
passive smoking: lung cancer and other disorders.  Washing-
ton, DC, ; 1992. 
18. Misra DP, Nguyen RH: Environmental tobacco smoke and low
birth weight: a hazard in the workplace?  Environ Health Perspect
1999, 107 Suppl 6:897-904.
19. Windham GC, Eaton A, Hopkins B: Evidence for an association
between environmental tobacco smoke exposure and birth-
weight: a meta-analysis and new data.  Paediatr Perinat Epidemiol
1999, 13:35-57.
20. Windham GC, Von Behren J, Waller K, Fenster L: Exposure to
environmental and mainstream tobacco smoke and risk of
spontaneous abortion.  Am J Epidemiol 1999, 149:243-247.
21. Andres RL, Day MC: Perinatal complications associated with
maternal tobacco use.  Semin Neonatol 2000, 5:231-241.
22. Hruba D, Kachlik P: Influence of maternal active and passive
smoking during pregnancy on birthweight in newborns.  Cent
Eur J Public Health 2000, 8:249-252.
23. Hull MG, North K, Taylor H, Farrow A, Ford WC: Delayed con-
ception and active and passive smoking. The Avon Longitu-
dinal Study of Pregnancy and Childhood Study Team.  Fertil
Steril 2000, 74:725-733.
24. Kukla L, Hruba D, Tyrlik M: Smoking and damages of reproduc-
tion: evidence of ELSPAC.  Cent Eur J Public Health 2001, 9:59-63.
25. Mitchell EA, Thompson JM, Robinson E, Wild CJ, Becroft DM, Clark
PM, Glavish N, Pattison NS, Pryor JE: Smoking, nicotine and tar
and risk of small for gestational age babies.  Acta Paediatr 2002,
91:323-328.
26. Dejmek J, Solansk y I, Podrazilova K, Sram RJ: The exposure of non-
smoking and smoking mothers to environmental tobacco
smoke during different gestational phases and fetal growth.
Environ Health Perspect 2002, 110:601-606.
27. Berthiller J, Sasco AJ: [Smoking (active or passive) in relation to
fertility, medically assisted procreation and pregnancy].  J
Gynecol Obstet Biol Reprod (Paris) 2005, 34 Spec No 1:3S47-54.
28. Kharrazi M, DeLorenze GN, Kaufman FL, Eskenazi B, Bernert JTJ,
Graham S, Pearl M, Pirkle J: Environmental tobacco smoke and
pregnancy outcome.  Epidemiology 2004, 15:660-670.
29. Ojima T, Uehara R, Watanabe M, Tajimi M, Oki I, Nakamura Y: Pop-
ulation attributable fraction of smoking to low birth weight
in Japan.  Pediatr Int 2004, 46:264-267.
Additional File 1
Video movie showing a stained oocyte cumulus complex (blue) being pick-
up by a hamster infundibulum. The complex adheres to the surface of the 
oviduct and is pulled along towards the ostium by ciliary beating. 
Reprinted from Molec Biol Cell 10:5–9, 1999 (with permission).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-3-52-S1.mov]
Additional File 2
Video movies showing a control (right) and smoke treated infundibulum. 
The oocyte cumulus complex (blue) on the control oviduct moves over the 
surface of the infundibulum and is picked up at the normal rate. In the 
smoke exposed preparation, the oocyte cumulus complex barely moves dur-
ing the same interval of time. Reprinted from Molec Biol Cell 10:5–9, 
1999 (with permission).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7827-3-52-S2.mov]Page 13 of 17
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/5230. Goel P, Radotra A, Singh I, Aggarwal A, Dua D: Effects of passive
smoking on outcome in pregnancy.  J Postgrad Med 2004,
50:12-16.
31. Neal MS, Hughes EG, Holloway AC, Foster WG: Sidestream
smoking is equally as damaging as mainstream smoking on
IVF outcomes.  Hum Reprod 2005.
32. Smoking and infertility.  Fertil Steril 2004, 81:1181-1186.
33. Ashmead GG: Smoking and pregnancy.  J Matern Fetal Neonatal
Med 2003, 14:297-304.
34. Higgins S: Smoking in pregnancy.  Curr Opin Obstet Gynecol 2002,
14:145-151.
35. Harper JK: Gamete and Zygote Transport.  In The Physiology of
Reproduction second edition. Edited by: Knobil E and Neill JD. New
York, Raven Press; 1994:123-185. 
36. Puikkinen MO: Oviductal function is critical for very early
human life.  Annals of Medicine 1995, 27:307-310.
37. Buhi WC, Alvarez IM, Kouba AJ: Oviductal regulation of fertili-
zation and early embryonic development.  Journal of Reproduc-
tion and Fertility 1997, 52:285-300.
38. Hunter RH, Rodriguez-Martinez H: Capacitation of mammalian
spermatozoa in vivo, with a specific focus on events in the
Fallopian tubes.  Mol Reprod Dev 2004, 67:243-250.
39. Hunter RH: Fallopian tube physiology: preliminaries to mon-
ospermic fertilization and cellular events post-fertilization.
Ernst Schering Res Found Workshop 2005:245-261.
40. Killian GJ: Evidence for the role of oviduct secretions in sperm
function, fertilization and embryo development.  Animal Repro-
ductive Science 2004, 82-83:141-153.
41. Hunter RH: The Fallopian tubes in domestic mammals: how
vital is their physiological activity?  Reprod Nutr Dev 2005,
45:281-290.
42. Suarez SS: Formation of a reservoir of sperm in the oviduct.
Reproduction in Domestic Animals 2002, 37:140-143.
43. Croxatto HB: Physiology of gamete and embryo transport
through the fallopian tube.  Reprod Biomed Online 2002,
4:160-169.
44. Menezo Y, Guerin P: The mammalian oviduct: biochemistry
and physiology.  European Journal of Obstetrics, Gynecology, and Repro-
ductive Biology 1997, 73:99-104.
45. Talbot P, Geiske C, Knoll M: Oocyte pick-up by the mammalian
oviduct.  Molec Biol Cell 1999, 10:5-8.
46. Talbot P, DiCarlantonio G: The oocyte-cumulus complex:
ultrastructure of the extracellular components in hamsters
and mice.  Gam Res 1984, 10:127-142.
47. Yanagimachi R: Fertilization in mammals.  Tokai J Exp Clin Med
1984, 9:81-85.
48. Motta PM, Nottola SA, Pereda J, Croxatto HB, Familiari G:
Ultrastructure of human cumulus oophorus: a transmission
electron microscopic study on oviductal oocytes and ferti-
lized eggs.  Hum Reprod 1995, 10:2361-2367.
49. Ball GD, Bellin ME, Ax RL, First NL: Glycosaminoglycans in
bovine cumulus-oocyte complexes: morphology and
chemistry.  Mol Cell Endocrinol 1982, 28:113-122.
50. Dandekar P, Aggelar J, Talbot P: Structure, distribution, and
composition of the extracellular matrix of human oocytes
and cumulus masses.  Hum Reprod 1992, 7:391-398.
51. Dandekar P, Talbot P: Perivitelline space of mammalian
oocytes: extracellular matrix of unfertilized oocytes and for-
mation of a cortical granule envelope following fertilization.
Molec Reprod Develop 1992, 31:135-143.
52. Talbot P, DiCarlantonio G: Ultrastructure of opossum oocyte
investing coats and their sensitivity to trypsin and
hyaluronidase.  Dev Biol 1984, 103:159-167.
53. Eppig JJ: FSH stimulates hyaluronic acid synthesis by oocyte-
cumulus cell complexes from mouse preovulatory follicles.
Nature 1979, 281:483-484.
54. Eppig JJ: Prostaglandin E2 stimulates cumulus expansion and
hyaluronic acid synthesis by cumuli oophori isolated from
mice.  Biol Reprod 1981, 25:191-195.
55. Talbot P, Franklin LE: Hamster sperm hyaluronidase: I. A bio-
assay procedure based on cumulus dispersion rate.  J Expt Zool
1974, 189:311-320.
56. Chen L, Mao SJ, Larsen WJ: Identification of a factor in fetal
bovine serum that stabilizes the cumulus extracellular
matrix. A role for a member of the inter-alpha-trypsin inhib-
itor family.  J Biol Chem 1992, 267:12380-12386.
57. Chen L, Mao SJ, McLean LR, Powers RW, Larsen WJ: Proteins of
the inter-alpha-trypsin inhibitor family stabilize the cumulus
extracellular matrix through their direct binding with
hyaluronic acid.  J Biol Chem 1994, 269:28282-28287.
58. Hess KA, Chen L, Larsen WJ: Inter-alpha-inhibitor binding to
hyaluronan in the cumulus extracellular matrix is required
for optimal ovulation and development of mouse oocytes.
Biol Reprod 1999, 61:436-443.
59. Carrette O, Nemade RV, Day AJ, Brickner A, Larsen WJ: TSG-6 is
concentrated in the extracellular matrix of mouse cumulus
oocyte complexes through hyaluronan and inter-alpha-
inhibitor binding.  Biol Reprod 2001, 65:301-308.
60. Mukhopadhyay D, Hascall VC, Day AJ, Salustri A, Fulop C: Two dis-
tinct populations of tumor necrosis factor-stimulated gene-
6 protein in the extracellular matrix of expanded mouse
cumulus cell-oocyte complexes.  Arch Biochem Biophys 2001,
394:173-181.
61. Rugg MS, Willis AC, Mukhopadhyay D, Hascall VC, Fries E, Fulop C,
Milner CM, Day AJ: Characterization of complexes formed
between TSG-6 and inter-alpha-inhibitor that act as inter-
mediates in the covalent transfer of heavy chains onto
hyaluronan.  J Biol Chem 2005, 280:25674-25686.
62. Fulop C, Szanto S, Mukhopadhyay D, Bardos T, Kamath RV, Rugg MS,
Day AJ, Salustri A, Hascall VC, Glant TT, Mikecz K: Impaired cumu-
lus mucification and female sterility in tumor necrosis fac-
tor-induced protein-6 deficient mice.  Development 2003,
130:2253-2261.
63. Clewe TH, Mastroianni LJ: Mechanisms of ovum pickup. I. Func-
tional capacity of rabbit oviducts ligated near the fimbria.
Fertil Steril 1958, 9:13-17.
64. Blandau R: Gamete transport - comparative aspects.  In The
Mammalian Oviduct Edited by: Hafez ESE and Blandau R. Chicago, Uni-
versity of Chicago Press; 1969:129-162. 
65. Blandau R, Verdugo P: An overview of gamete transport - com-
parative aspects.  In Ovum Tranport and Fertility Regulation Edited by:
Harper MJK, J. PC, Adams CE, Coutinho EM and Paton DM. Copen-
hagen, Scriptor; 1976:138-146. 
66. Mahi-Brown CA, Yanagimachi R: Parameters influencing ovum
pickup by oviductal fimbria in the golden hamster.  Gam Res
1983, 8:1-10.
67. Norwood JT, Hein CE, Halbert SA, Anderson RGW: Polycationic
macromolecules inhibit cilia-mediated ovum transport.  Proc
Natl Acad Sci 1978, 75:4413-4416.
68. Norwood JT, Anderson RGW: Evidence that adhesive sites on
the tips of oviduct cilia membranes are required for ovum
pickup in situ.  Biol Reprod 1980, 23:788-791.
69. Nakatani T, Shinohara H, Takeda S, Morisawa S, Matsuda T: Mor-
phology of the intercapsular segment of the oviduct of the
golden hamster with special reference to ovum-transit from
ruptured follicles to the ampulla.  Experientia 1985, 41:368-370.
70. DiCarlantonio G, Shaoulian R, Knoll M, Magers T, Talbot P: Analysis
of ciliary beat frequencies in hamster oviducal explants.  J Exp
Zool 1995, 272:142-152.
71. Huang S, Driessen N, Knoll M, Talbot P: In vitro analysis of oocyte
cumulus complex pick-up rate in the hamster Mesocricetus
auratus.  Molecular Reproduction and Development 1997, 47:312-322.
72. Lam X, Gieseke C, Knoll M, Talbot P: Assay and importance of
adhesive interaction between hamster (Mesocricetus aura-
tus) oocyte-cumulus complexes and the oviductal
epithelium.  Biol Reprod 2000, 62:579-588.
73. Talbot P, Shur BD, Myles DG: Cell adhesion and fertilization:
steps in oocyte transport, sperm-zona pellucida interactions,
and sperm-egg fusion.  Biol Reprod 2003, 68:1-9.
74. Dirksen ER, Satir P: Ciliary activity in the mouse oviduct as
studied by transmission and scanning electron microscopy.
Tissue Cell 1972, 4:389-404.
75. Gordts S, Campo R, Romauts L, Brosen I: Endoscopic visualiza-
tion of the process of fimbrial ovum retrieval in the human.
Human Reproduction 1998, 13:1425-1428.
76. Halbert SA, Tam PY, Blandau RJ: Egg transport in the rabbit ovi-
duct: the roles of cilia and muscle.  Science 1976, 191:1052-1053.
77. Riveles K, Iv M, Arey J, Talbot P: Pyridines in cigarette smoke
inhibit hamster oviductal functioning in picomolar doses.
Reprod Toxicol 2003, 17:191-202.Page 14 of 17
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/5278. Gaddum-Rosse P, Blandau RJ: Comparative observations on cili-
ary currents in mammalian oviducts.  Biol Reprod 1976,
14:605-609.
79. Suginami H, Yano K, Watanabe K, Matsuura S: A factor inhibiting
ovum capture by the oviductal fimbriae present in endome-
triosis peritoneal fluid.  Fertil Steril 1986, 46:1140-1146.
80. Suginami H, Yano K: An ovum capture inhibitor (OCI) in
endometriosis peritoneal fluid: an OCI-related membrane
responsible for fimbrial failure of ovum capture.  Fertil Steril
1988, 50:648-653.
81. Mastroianni LJ: The fallopian tube and reproductive health.
Journal of Pediatric and Adolescent Gynecology 1999, 12:121-126.
82. Buhi WC, Alvarez IM, Kouba AJ: Secreted proteins of the
oviduct.  Cells Tissues Organs 2000, 166:165-179.
83. Suarez SS, Katz DF, Owen DH, Andrew JB, Powell RL: Evidence for
the function of hyperactivated motility in sperm.  Biol Reprod
1991, 44:375-381.
84. Suarez SS, Ho HC: Hyperactivation of mammalian sperm.  Cell
Mol Biol (Noisy-le-grand) 2003, 49:351-356.
85. McComb PF, Halbert SA, Gomel V: Pregnancy, ciliary transport,
and the reversed ampullary segment of the rabbit fallopian
tube.  Fertil Steril 1980, 34:386-390.
86. McComb PF, Newman H, Halbert SA: Reproduction in rabbits
after excision of the oviductal isthmus, ampullary-isthmic
junction, and uteroisthmic junction.  Fertil Steril 1981,
36:669-677.
87. Ortiz ME, Bedregal P, Carajal MI, Croxatto HB: Fertilized and
unfertilized ova are transported at different rates by the
hamster oviduct.  Biol Reprod 1986, 34:777-781.
88. Velasquez LA, Aguilera JG, Croxatto HB: Possible role of platelet-
activating factor in embryonic signaling during oviductal
transport in the hamster.  Biol Reprod 1995, 52:1302-1306.
89. Hermoso M, Barrera N, Morales B, Perez S, Villalon M: Platelet acti-
vating factor increases ciliary activity in the hamster oviduct
through epithelial production of prostaglandin E2.  Pflugers
Arch 2001, 442:336-345.
90. Velasquez LA, Maisey K, Fernandez R, Valdes D, Cardenas H, Imarai
M, Delgado J, Aguilera J, Croxatto HB: PAF receptor and PAF
acetylhydrolase expression in the endosalpinx of the human
Fallopian tube: possible role of embryo-derived PAF in the
control of embryo transport to the uterus.  Hum Reprod 2001,
16:1583-1587.
91. Ortiz ME, Llados C, Croxatto HB: Embryos of different ages
transferred to the rat oviduct enter the uterus at different
times.  Biology of Reproduction 1989, 41:381-384.
92. Trejo CA, Navarro MC, Ambriz GD, Rosado A: Effect of maternal
age and parity on preimplantation embryo development and
transport in the golden hamster (Mesocricetus auratus).  Lab
Anim 2005, 39:290-297.
93. Halbert SA, Becker DR, Szal SE: Ovum transport in the rat ovi-
ductal ampulla in the absence of muscle contractility.  Biol
Reprod 1989, 40:1131-1136.
94. Woodruff JDPCJ: The Fallopian Tube.  Baltimore, Williams and
Williams; 1969. 
95. Halbert SA, Tam PY, Adams RJ, Blandau RJ: An analysis of the
mechanisms of egg transport in the ampulla of the rabbit
oviduct.  Gynecol Invest 1976, 7:306-320.
96. Bourdage RJ, Halbert SA: Quantification of intraluminal motion
of surrogate ova in the rabbit oviductal isthmus.  Biol Reprod
1984, 30:1124-1129.
97. Perez-Martinez S, Viggiano M, Franchi AM, Herrero MB, Ortiz ME,
Gimeno MF, Villalon M: Effect of nitric oxide synthase inhibitors
on ovum transport and oviductal smooth muscle activity in
the rat oviduct.  Journal of Reproduction and Fertility 2000,
118:111-117.
98. Bourdage RJ, Halbert SA: Distribution of embryos and 500-
microM microspheres in the rabbit oviduct: controls for
acute motion analysis during transport.  Biol Reprod 1988,
38:282-291.
99. Owman C, Rosenbren E, Sjoberg NO: Adrenergic innervation of
the human female reproductive organs: a histochemical and
chemical investigation.  Obstet Gynecol 1967, 30:763-773.
100. Paton DM, Widdicombe JH, Rheaume DE, Johns A: The role of the
adrenergic innervation of the oviduct in the regulation of
mammalian ovum transport.  Pharmacol Rev 1977, 29:67-102.
101. Laszlo A, Nadasy GL, Monos E, Zsolnai B: Effect of pharmacolog-
ical agents on the activity of the circular and longitudinal
smooth muscle layers of human fallopian tube ampullar
segments.  Acta Physiol Hung 1988, 72:123-133.
102. Samuelson UE, Sjostrand NO: Myogenic and neurogenic control
of electrical and mechanical activity in human oviductal
smooth muscle.  Acta Physiol Scand 1986, 126:355-363.
103. Lindblom B, Hamberger L: Cyclic AMP and contractility of the
human oviduct.  Biology of Reproduction 1980, 22:173-178.
104. Spilman CH, Harper MJ: Effects of prostaglandins on oviductal
motility and egg transport.  Gynecologic Investigation 1975,
6:186-205.
105. Lindblom B, Hamberger L, Wiqvist N: Differentiated contractile
effects of prostaglandins E and F on the isolated circular and
longitudinal smooth muscle of the human oviduct.  Fertil Steril
1978, 30:553-559.
106. Tan HN, Liu Y, Diao HL, Yang ZM: Cyclooxygenases and prostag-
landin E synthases in preimplantation mouse embryos.
Zygote 2005, 13:103-108.
107. Arbab F, Goldsby J, Matijevic-Aleksic , Huang G, Ruan KH, Huang JC:
Prostacyclin is an autocrine regulator in the contraction of
oviductal smooth muscle.  Human Reproduction 2002,
17:3063-3059.
108. Ekerhovd E, Brannstrom M, Weijdegard B, Norstrom A: Localiza-
tion of nitric oxide synthase and effects of nitric oxide donors
on the human Fallopian tube.  Mol Hum Reprod 1999,
5:1040-1047.
109. Ekerhovd E, Brannstrom M, Alexandersson M, Norstrom A: Evi-
dence for nitric oxide mediation of contractile activity in iso-
lated strips of the human Fallopian tube.  Hum Reprod 1997,
12:301-305.
110. Priyadarsana M, Wijayagunawardane B, Miyamoto A: Endothelin-1
system in the bovine oviduct: a regulator of local contraction
and gamete transport.  J Cardiovasc Pharmacol 2004, 44 Suppl
1:S248-51.
111. Wijayagunawardane MP, Miyamoto A, Taquahashi Y, Acosta TJ,
Nishimura M, Sato K: Angiotensin II and atrial natriuretic pep-
tide in the cow oviductal contraction in vitro: direct effect
and local secretion of prostaglandins, endothelin-1, and angi-
otensin II.  Biol Reprod 2001, 65:799-804.
112. Wang H, Guo Y, Wang D, Kingsley PJ, Marnett LJ, Das SK, DuBois
RN, Dey SK: Aberrant cannabinoid signaling impairs oviductal
transport of embryos.  Nat Med 2004, 10:1074-1080.
113. Paria BC, Huet-Hudson YM, Dey SK: Blastocyst's state of activity
determines the "window" of implantation in the receptive
mouse uterus.  Proc Natl Acad Sci U S A 1993, 90:10159-10162.
114. Carson DD, Bagchi I, Dey SK, Enders AC, Fazleabas AT, Lessey BA,
Yoshinaga K: Embryo implantation.  Dev Biol 2000, 223:217-237.
115. Cummings AM, Perreault SD: Methoxychlor accelerates embryo
transport through the rat reproductive tract.  Toxicol Appl
Pharmacol 1990, 102:110-116.
116. Coutinho EM, Maia H, Nascimento L: The response of the human
Fallopian tube to ergonovine and methyl-ergonovine in vivo.
Am J Obstet Gynecol 1976, 126:48-54.
117. Neri A, Eckerling B: Influence of smoking and adrenaline
(epinephrine) on the uterotubal insufflation test (Rubin
test).  Fertil Steril 1969, 20:818-828.
118. Ruckebusch Y: Relationship between the electrical activity of
the oviduct and the uterus of the rabbit in vivo.  J Reprod Fertil
1975, 45:73-82.
119. Magers T, Talbot P, DiCarlantonio G, Knoll M, Demers D, Tsai I,
Hoodbhoy T: Cigarette smoke inhalation affects the repro-
ductive system of female hamsters.  Reprod Toxicol 1995,
9:513-525.
120. DiCarlantonio G, Talbot P: Inhalation of mainstream and side-
stream cigarette smoke retards embryo transport and slows
muscle contraction in oviducts of hamsters (Mesocricetus
auratus).  Biol Reprod 1999, 61:651-656.
121. Jin Z, Jin M, Nilsson BO, Roomans GM: Effects of nicotine admin-
istration on elemental concentrations in mouse granulosa
cells, maturing oocytes and oviduct epithelium studied by X-
ray microanalysis.  Journal of Submicroscopic Cytology and Pathology
1998, 30:517-520.
122. Rice C, Yoshinaga K: Effect of nicotine on oviducal lactate dehy-
drogenase during early pregnancy in the rat.  Biol Reprod 1980,
23:445-451.Page 15 of 17
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52123. Yoshinaga K, Rice C, Krenn J, Pilot CL: Effects of nicotine on early
pregnancy in the rat.  Biol Reprod 1979, 20:294-303.
124. Mitchell JH, Hammer RE: Effects of nicotine on oviducal blood
flow and embryo development in the rat.  J Reprod Fertil 1985,
74:71-   ..
125. Garcia-Pascual A, Labadia A, Triguero D, Costa G: Local regulation
of oviductal blood flow.  General Pharmacology 1996,
27:1303-1310.
126. Neri A, Marcus SL: Effect of nicotine on the motility of the ovi-
ducts in the Rhesus monkey: a preliminary report.  J Reproduc-
tion Fertility 1972, 31:91-  ..
127. Chung PH, Yeko TR, Mayer JC, Clark B, Welden SW, Maroulis GB:
Gamete intrafallopian transfer. Does smoking play a role?  J
Reprod Med 1997, 42:65-70.
128. Knoll M, Shaoulian R, Magers T, Talbot P: Ciliary beat frequency
of hamster oviducts is decreased in vitro by exposure to solu-
tions of mainstream and sidestream cigarette smoke.  Biol
Reprod 1995, 53:29-37.
129. Knoll M, Talbot P: Cigarette smoke inhibits oocyte cumulus
complex pick-up by the oviduct independent of ciliary beat
frequency.  Reproductive Toxicology 1998, 12:57-68.
130. Riveles K, Roza R, Kwan D, Talbot P: Pyridines that inhibit
diverse biological processes are more concentrated in side-
stream than mainstream smoke solutions from commercial
cigarettes: ; Allergan, Irvine, Califoronia.  ; 2003. 
131. Riveles K, Roza R, Arey J, Talbot P: Pyrazine derivatives in ciga-
rette smoke inhibit hamster oviductal functioning.  Reprod Biol
Endocrinol 2004, 2:23.
132. Riveles K, Roza R, Talbot P: Phenols, Quinolines, Indoles, Ben-
zene, and 2-Cyclopenten-1-ones are Oviductal Toxicants in
Cigarette Smoke.  Toxicol Sci 2005.
133. Gieseke C, Talbot P: Cigarette Smoke Inhibits Hamster
Oocyte Pickup by Increasing Adhesion Between the Oocyte
Cumulus Complex and Oviductal Cilia.  Biol Reprod 2005.
134. Riveles K: Identification and Quantification of Toxicants in
Mainstream and Sidestream Smoke that Affect Hamster
Oviductal Functioning.  In Interdepartmental Graduate Program in
Environmental Toxicology Riverside, University of California; 2004. 
135. Breland AB, Acosta MC, Eissenberg T: Tobacco specific nitro-
samines and potential reduced exposure products for smok-
ers: a preliminary evaluation of Advance.  Tob Control 2003,
12:317-321.
136. Vrsanska S, Nagyova E, Mlynarcikova A, Fickova M, Kolena J: Com-
ponents of cigarette smoke inhibit expansion of oocyte-
cumulus complexes from porcine follicles.  Physiological
Research 2003, 52:383-387.
137. Kalman D: The subjective effects of nicotine: methodological
issues, a review of experimental studies, and recommenda-
tions for future research.  Nicotine Tob Res 2002, 4:25-70.
138. Yoshimasu K, Kiyohara C: Genetic influences on smoking
behavior and nicotine dependence: a review.  J Epidemiol 2003,
13:183-192.
139. Le Houezec J: Role of nicotine pharmacokinetics in nicotine
addiction and nicotine replacement therapy: a review.  Int J
Tuberc Lung Dis 2003, 7:811-819.
140. Adams JD, Lee SJ, Hoffmann D: Carcinogenic agents in cigarette
smoke and the influence of nitrate on their formation.  Car-
cinogenesis 1984, 5:221-223.
141. Smith CJ, Livingston SD, Doolittle DJ: An international literature
survey of "IARC group 1 carcinogens" reported in main-
stream cigarette smoke.  Food and Chemical Toxicology 1997,
35:1107-1130.
142. Zedeck MS: Polycyclic aromatic hydrocarbons: a review.  J Envi-
ron Pathol Toxicol 1980, 3:537-567.
143. Santodonato J: Review of the estrogenic and antiestrogenic
activity of polycyclic aromatic hydrocarbons: relationship to
carcinogenicity.  Chemosphere 1997, 34:835-848.
144. Besarati Nia A, Kleinjans JC, Van Schooten FJ: Biomonitoring of
tobacco smoke carcinogenicity by dosimetry of DNA
adducts and genotyping and phenotyping of biotransforma-
tional enzymes: a review on polycyclic aromatic
hydrocarbons.  Biomarkers 2002, 7:209-229.
145. Wu W, Ashley DL, Watson CH: Simultaneous determination of
five tobacco-specific nitrosamines in mainstream cigarette
smoke by isotope dilution liquid chromatography/electro-
spray ionization tandem mass spectrometry.  Anal Chem 2003,
75:4827-4832.
146. Stepanov I, Hecht SS: Tobacco-specific nitrosamines and their
pyridine-N-glucuronides in the urine of smokers and smoke-
less tobacco users.  Cancer Epidemiol Biomarkers Prev 2005,
14:885-891.
147. Benowitz NL, Jacob P: Effects of cigarette smoking and carbon
monoxide on nicotine and cotinine metabolism.  Clin Pharma-
col Ther 2000, 67:653-659.
148. Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL: Cardiovas-
cular effects of carbon monoxide and cigarette smoking.  J
Am Coll Cardiol 2001, 38:1633-1638.
149. Eke BC, Iscan M: Effects of cigarette smoke with different tar
contents on hepatic and pulmonary xenobiotic metabolizing
enzymes in rats.  Hum Exp Toxicol 2002, 21:17-23.
150. Foy JW, Bombick BR, Bombick DW, Doolittle DJ, Mosberg AT,
Swauger JE: A comparison of in vitro toxicities of cigarette
smoke condensate from Eclipse cigarettes and four com-
mercially available ultra low-"tar" cigarettes.  Food Chem
Toxicol 2004, 42:237-243.
151. Harris JE, Thun MJ, Mondul AM, Calle EE: Cigarette tar yields in
relation to mortality from lung cancer in the cancer preven-
tion study II prospective cohort, 1982-8.  Bmj 2004, 328:72.
152. Jenkins RA: Occurrence of selected metals in cigarette tobac-
cos and smoke.  IARC Sci Publ 1986:129-138.
153. Ronco AM, Arguello G, Munoz L, Gras N, Llanos M: Metals content
in placentas from moderate cigarette consumers: correla-
tion with newborn birth weight.  Biometals 2005, 18:233-241.
154. Wynder EL, Hoffmann D: Experimental tobacco carcinogenesis.
Science 1968, 162:862-871.
155. Wynder EL, Hoffmann D: A study of tobacco carcinogenesis.
Cancer 1969, 24:289-301.
156. Hoffmann D, Bondinell WE, Wynder EL: Carcinogenicity of
methylchrysenes.  Science 1974, 183:215-216.
157. Hoffmann D, Adams JD, Brunnemann KD, Hecht SS: Assessment of
tobacco-specific N-nitrosamines in tobacco products.  Cancer
Res 1979, 39:2505-2509.
158. Anderson LM, Hecht SS, Dixon DE, Dove LF, Kovatch RM, Amin S,
Hoffmann D, Rice JM: Evaluation of the transplacental tumori-
genicity of the tobacco-specific carcinogen 4-(methylnitro-
samino)-1-(3-pyridyl)-1-butanone in mice.  Cancer Research
1989, 49:3770-3775.
159. Risner CH, Martin P: Quantitation of formaldehyde, acetalde-
hyde, and acetone in sidestream cigarette smoke by high-
performance liquid chromatography.  J Chromatogr Sci 1994,
32:76-82.
160. Hoffmann D, Djordjevic MV, Hoffmann I: The changing cigarette.
Preventive Medicine 1997, 26:437-434.
161. Rodgman A, Smith CJ, Perfetti TA: The composition of cigarette
smoke: a retrospective, with emphasis on polycyclic
components.  Human and Experimental Toxicology 2000, 19:573-595.
162. Smith CJ, Hansch C: The relative toxicity of compounds in
mainstream cigarette smoke condensate.  Food and Chemical
Toxicology 2000, 38:637-646.
163. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hai-
naut P: Tobacco smoke carcinogens, DNA damage and p53
mutations in smoking-associated cancers.  Oncogene 2002,
21:7435-7451.
164. Hoffmann D, Raineri R, Hecht SS, Maronpot R, Wynder EL: A study
of tobacco carcinogenesis. XIV. Effects of N'nitrosonornico-
tine and N'-nitrosoanabasine in rats.  Journal of the National Can-
cer Institute 1975, 55:977-979.
165. Hoffmann D, Rivenson A, Hecht SS: The biological significance of
tobacco-specific N-nitrosamines: smoking and adenocarci-
noma of the lung.  Critical Reviews in Toxicology 1996, 26:199-211.
166. Nordskog BK, Blixt AD, Morgan WT, Fields WR, Hellmann GM:
Matrix-degrading and pro-inflammatory changes in human
vascular endothelial cells exposed to cigarette smoke
condensate.  Cardiovascular Toxicology 2003, 3:101-117.
167. Bond JA, Gown AM, Yang HL, Benditt EP, Juchau MR: Further inves-
tigations of the capacity of polynuclear aromatic hydrocar-
bons to elicit atherosclerotic lesions.  J Toxicol Environ Health
1981, 7:327-335.
168. Hough JL, Baird MB, Sfeir GT, Pacini CS, Darrow D, Wheelock C:
Benzo(a)pyrene enhances atherosclerosis in White Carneau
and Show Racer pigeons.  Arterioscler Thromb 1993, 13:1721-1727.Page 16 of 17
(page number not for citation purposes)
Reproductive Biology and Endocrinology 2005, 3:52 http://www.rbej.com/content/3/1/52Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
169. Batastini G, Penn A: An ultrastructural comparison of carcino-
gen-associated and spontaneous aortic lesions in the
cockerel.  Am J Pathol 1984, 114:403-409.
170. Cox LR, Ramos K: Allylamine-induced phenotypic modulation
of aortic smooth muscle cells.  J Exp Pathol (Oxford) 1990,
71:11-18.
171. Ramos KS, Parrish AR: Growth-related signaling as a target of
toxic insult in vascular smooth muscle cells: implications in
atherogenesis.  Life Sci 1995, 57:627-635.
172. Ou X, Ramos KS: Proliferative responses of quail aortic
smooth muscle cells to benzo[a]pyrene: implications in
PAH-induced atherogenesis.  Toxicology 1992, 74:243-258.
173. Ballenger JJ: Experimental effect of cigarette smoke on human
respiratory cilia.  The New England Journal of Medicine 1960,
263:832-835.
174. Battista SP: Cilia toxic components of cigarette smoke.  Volume
# (NIH) 76-1221. Edited by: Wynder EL, Hoffman D and Gori GB.
DHEW; 1974:517-534. 
175. Dalhamm T: In  vivo and in viro ciliotoxic effects of tobacco
smoke.  Arch Environ Health 1970, 21:633-634.
176. Pettersson B, Curvall M, Enzell C: The inhibitory effect of
tobacco smoke compounds on ciliary activity.  European Journal
of Respiratory Diseases 1985, 139:89-92.
177. Stanley PJ, Wilson R, Greenstone MA, MacWilliam L, Cole PJ: Effect
of cigarette smoking on nasal mucociliary clearance and cil-
iary beat frequency.  Thorax 1986, 41:519-523.
178. Zayas JG, O'Brien DW, Tai S, Ding J, Lim L, King M: Adaptation of
an amphibian mucociliary clearance model to evaluate early
effects of tobacco smoke exposure.  Respir Res 2004, 5:9.
179. Wang H: Differential responses of Paramecium aurelia to cig-
arette smoke.  Nature 1963, 197:946-948.
180. Weiss W, Weiss WA: Effect of tobacco smoke solutions on
Paramecium.  Arch Env Health 1964, 9:500-504.
181. Walker TR, Kiefer JE: Ciliastatic components in the gas phase
of cigarette smoke.  Science 1966, 153:1248-1250.
182. Wynder EL, Goodman DA, Hoffmann D: Ciliatoxic components
in cigarette smoke. 3. In vitro comparison of different smoke
components.  Cancer 1965, 18:1652-1658.
183. Hahn HL, Kleinchrot D, Hansen D: Nicotine increases ciliary
beat frequency by a direct effect on respiratory cilia.  Clinical
Investigator 1992, 70:244-251.
184. Hastie AT, Patrick H, Fish JE: Inhibition and recovery of mam-
malian respiratory ciliary function after formaldehyde
exposure.  Toxicology anbd applied pharmacology 1990, 102:282-291.
185. Talbot P, DiCarlantonio G, Knoll M: Identification of cigarette
smoke components that alter functioning of hamster (Mes-
ocricetus auratus) oviducts in vitro.  Biol Reprod 1998,
58:1047-1053.
186. About: http://quitsmoking.about.com/od/cigaretteingredi-
ents/.  2004.
187. Ji L, Melkonian G, Riveles K, Talbot P: Identification of  pyridine
compounds in cigarette smoke solution that inhibit growth
of the chick chorioallantoic membrane.  Toxicological Sciences
2002, 69:217-225.
188. Melkonian G, Lautenschlager H, Wu M, Wang Y, Tong C, Riveles K,
Talbot P: Growth and angiogenesis are inhibited in developing
tissues by pyrazine and its derivatives.  Toxicological Sciences
2003, 74:393-401:.
189. Armitage AK, Dolery CT, Houseman TH, Lewis PJ, Turner DM:
Absorption and metabolism of  nicotine from cigarettes.  Br
Med L 1975, 4:313-316.
190. Russel MAH, Jarvis M, Feyerbend C: Relation of nicotine yield of
cigarettes to blood nicotine concentration in smokers.  British
Medical Journal 1980, 280:972-976.
191. Kogen MJ, Verebey K, Jaffee JH, Mule SJ: Simultaneous determina-
tion of nicotine and cotinine in human plasma by nitrogen
detection gas-liquid chromaography.  J Forensic Sci 1981,
26:6-11.
192. Brunneman KD, Stahnke G, Hoffman D: Chemical studies on
tobacco smoke. LXI. Volatile pyridines:quantitative analysis
in mainstream and sidestream smoke of cigarettes and
cigars.  Analytical Letters 1978, A11:545-560.
193. Nanni EJ, Lovette ME, Hicks RD, Fowler KW, Borgerding MF: Sepa-
ration and quantitation of phenolic compounds in main-
stream cigarette smoke by capillary gas chromatography
with mass spectrometry in the selected-ion mode.  Journal of
Chromatography 1990, 505:365-374.
194. Forehand JB, Dooly GL, Moldoveanu SC: Analysis of polycyclic
aromatic hydrocarbons, phenols and aromatic amines in
particulate phase cigarette smoke using simultaneous distil-
lation and extraction as a sole sample clean-up step.  J Chro-
matogr A 2000, 898:111-124.
195. McLachlan JA, Dames NM, Sieber SM, Fabro S: Accumulation of
nicotine in the uterine fluid of the six-day pregnant rabbit.
Fertil Steril 1976, 27:1204-1213.
196. McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM:
Nicotine and cotinine in the cervical mucus of smokers, pas-
sive smokers, and nonsmokers.  Cancer Epidemiol Biomarkers Prev
1992, 1:125-129.
197. Melikian AA, Sun P, Prokopczyk B, El-Bayoumy K, Hoffmann D, Wang
X, Waggoner S: Identification of benzo(a)pyrene metabolites
in cervical mucus and DNA adducts in cervical tissues in
humans by gas chromatography-mass spectrometry.  Cancer
Letters 1999, 146:127-134.
198. Sasson IM, Haley NJ, Hoffmann D, Wynder EL: Cigarette smoking
and neoplasia of the uterine cervix: smoke constituents in
cervical mucus.  The New England Journal of Medicine 1985,
812:315-316.
199. Paszkowski T: Concentration gradient of cotinine between
blood serum and preovulatory follicular fluid.  Ginekol Pol 1998,
69:1131-1136.
200. Zenzes MT, Reed TE, Wang P, Klein J: Cotinine, a major metab-
olite of nicotine, is detectable in follicular fluids of passive
smokers in in vitro fertilization therapy.  Fertil Steril 1996,
66:614-619.
201. Zenzes NT, Krishnan S, Krishnan B, Zhang H, Casper RF: Cadmium
accumulation in follicular fluid of women in in vitro fertiliza-
tion-embryo transfer is higher in smokers.  Fertility and Sterility
1995, 64:599-603.
202. Varga B, Zsolnai B, Paksy K, Naray M, Ungvary G: Age dependent
accumulation of cadmium in the human ovary.  Reproductive
Toxicology 1993, 7:225-228.
203. Paksy K, Varga B, Naray M, Olajos F, Folly G: Altered ovarian pro-
gesterone secretion induced by cadmium fails to interfere
with embryo transport in the oviduct of the rat.  Reprod Toxicol
1992, 6:77-83.
204. Watanabe T, Shimada T, Endo A: Mutagenic effects of cadmium
on mammalian oocyte chromosomes.  Mutation Research 1979,
67:349-356.Page 17 of 17
(page number not for citation purposes)
